ARTICLE | Company News
Baruch S. Blumberg Institute, OnCore Biopharma deal
January 5, 2015 8:00 AM UTC
The institute granted OnCore an exclusive, worldwide option to license products resulting from the partners’ collaboration to identify HBV and liver cancer targets, therapies and diagnostics. Under th...